IndiaTickerLatest filing: Caplin Point Laboratories Ltd - 524742 - Board Meeting Intimation for Approval Of Financial Results And Recommendation Of Final Dividend, If Any.
ObservedCompany dossier
Caplin Point Laboratories
NSE:CAPLIPOINT · ISIN INE475E01026
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Caplin Point Laboratories
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹493 Cr · PAT ₹140.1 Cr.
Exchange XBRLLatest ownership: promoter group 70.57% and public 29.43% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Caplin Point Laboratories Ltd - 524742 - Board Meeting Intimation for Approval Of Financial Results And Recommendation Of Final Dividend, If Any.
BSE · financial results
Observed
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Caplin Point Laboratories Limited
NSE · exchange filing
Observed
Source filing Caplin Point Laboratories Ltd - 524742 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Trading Window - Caplin Point Laboratories Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹493 Cr
- Profit after tax
- ₹140.1 Cr
- EPS
- ₹18.28
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 70.57%
- Public
- 29.43%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL